Auxeris, Ceros Pharmaceutical Inc. deal

Auxeris acquired all of the IP assets of musculoskeletal company Ceros in a mostly stock deal. The IP covers the use of beta blockers to prevent and treat osteoporosis. Auxeris hopes to enter the clin...